IS7742A - Nýjar kvínúklidín-afleiður og notkun þeirra - Google Patents

Nýjar kvínúklidín-afleiður og notkun þeirra

Info

Publication number: IS7742A
Authority: IS; Iceland
Prior art keywords: diseases; disorders; quinuclidine derivatives; nervous system; disorders related
Prior art date: 2002-08-14

Application number

IS7742A

Other languages

English (en)

Inventor

Peters Dan

M. Olsen Gunnar

östergaard Nielsen Elsebet

K. Ahring Philip

Dyhring Jörgensen Tino

Original Assignee

Neurosearch A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-14

Filing date

2005-03-14

Publication date

2005-03-14

2005-03-14 Application filed by Neurosearch A/S filed Critical Neurosearch A/S

2005-03-14 Publication of IS7742A publication Critical patent/IS7742A/is

Links

150000008584 quinuclidines Chemical class 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 8
201000010099 disease Diseases 0.000 abstract 4
208000035475 disorder Diseases 0.000 abstract 4
210000003169 central nervous system Anatomy 0.000 abstract 2
210000001428 peripheral nervous system Anatomy 0.000 abstract 2
208000017701 Endocrine disease Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000002193 Pain Diseases 0.000 abstract 1
208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
230000001713 cholinergic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000030172 endocrine system disease Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
230000016160 smooth muscle contraction Effects 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pregnancy & Childbirth (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Psychology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS7742A 2002-08-14 2005-03-14 Nýjar kvínúklidín-afleiður og notkun þeirra IS7742A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200201208		2002-08-14
DKPA200201472		2002-10-02
PCT/DK2003/000538 WO2004016608A1 (en)	2002-08-14	2003-08-13	Novel quinuclidine derivatives and their use

Publications (1)

Publication Number	Publication Date
IS7742A true IS7742A (is)	2005-03-14

Family

ID=31889349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7742A IS7742A (is)	2002-08-14	2005-03-14	Nýjar kvínúklidín-afleiður og notkun þeirra

Country Status (18)

Country	Link
US (2)	US20050245567A1 (is)
EP (2)	EP1532144B1 (is)
JP (1)	JP2005538187A (is)
KR (1)	KR20050055711A (is)
CN (1)	CN100513406C (is)
AT (1)	ATE384720T1 (is)
AU (1)	AU2003250322B2 (is)
BR (1)	BR0313153A (is)
CA (1)	CA2493245A1 (is)
DE (1)	DE60318860T2 (is)
IL (1)	IL166254A0 (is)
IS (1)	IS7742A (is)
MX (1)	MXPA05001702A (is)
NO (1)	NO20051264L (is)
NZ (1)	NZ538058A (is)
PL (1)	PL375533A1 (is)
RU (1)	RU2323217C2 (is)
WO (1)	WO2004016608A1 (is)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6262265A (ja) *	1985-09-13	1987-03-18	Hitachi Ltd	復水器自動検査補修システム
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
GB0220581D0 (en)	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
EP1603585A2 (en)	2003-03-14	2005-12-14	Bristol-Myers Squibb Company	Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
US7750022B2 (en)	2003-08-13	2010-07-06	Neurosearch A/S	Quinuclidine derivatives and their pharmaceutical use
US7160876B2 (en)	2003-12-22	2007-01-09	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
CA2551486A1 (en) *	2003-12-22	2006-06-22	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
US7655657B2 (en)	2003-12-22	2010-02-02	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
US7309699B2 (en)	2003-12-22	2007-12-18	Abbott Laboratories	3-Quinuclidinyl amino-substituted biaryl derivatives
US20050137203A1 (en) *	2003-12-22	2005-06-23	Jianguo Ji	3-quinuclidinyl amino-substituted biaryl derivatives
US20050245531A1 (en) *	2003-12-22	2005-11-03	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
US7241773B2 (en)	2003-12-22	2007-07-10	Abbott Laboratories	3-quinuclidinyl heteroatom bridged biaryl derivatives
US20050137398A1 (en) *	2003-12-22	2005-06-23	Jianguo Ji	3-Quinuclidinyl heteroatom bridged biaryl derivatives
US7365193B2 (en)	2004-02-04	2008-04-29	Abbott Laboratories	Amino-substituted tricyclic derivatives and methods of use
US20050171079A1 (en) *	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
SE0400970D0 (sv) *	2004-04-14	2004-04-14	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
PE20060437A1 (es)	2004-06-18	2006-06-08	Novartis Ag	COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) *	2004-07-14	2004-08-18	Novartis Ag	Organic compounds
GB0424564D0 (en)	2004-11-05	2004-12-08	Novartis Ag	Organic compounds
AU2005319248A1 (en) *	2004-12-22	2006-06-29	Memory Pharmaceuticals Corporation	Nicotinic alpha-7 receptor ligands and preparation and uses thereof
CN101312968A (zh) *	2005-09-23	2008-11-26	记忆药物公司	吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途
GB0521508D0 (en) *	2005-10-21	2005-11-30	Novartis Ag	Organic compounds
GB0525673D0 (en) *	2005-12-16	2006-01-25	Novartis Ag	Organic compounds
GB0525672D0 (en)	2005-12-16	2006-01-25	Novartis Ag	Organic compounds
FR2904002A1 (fr) *	2006-07-19	2008-01-25	Galderma Res & Dev S N C Snc	Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
US8314119B2 (en)	2006-11-06	2012-11-20	Abbvie Inc.	Azaadamantane derivatives and methods of use
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
US8383657B2 (en)	2007-12-21	2013-02-26	Abbott Laboratories	Thiazolylidine urea and amide derivatives and methods of use thereof
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
US20120157464A1 (en) *	2009-07-23	2012-06-21	Novartis Ag	Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxia
JO3250B1 (ar)	2009-09-22	2018-09-16	Novartis Ag	إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
KR20180101641A (ko)	2010-05-17	2018-09-12	포럼 파마슈티칼즈 인크.	(R)-7-클로로-N-(퀴누클리딘-3-일)벤조[b]티오펜-2-카르복사미드 히드로클로리드 모노히드레이트의 결정질 형태
CN103180321A (zh)	2010-09-23	2013-06-26	Abbvie公司	氮杂金刚烷衍生物的一水合物
US20120220729A1 (en) *	2011-02-28	2012-08-30	Boehringer Ingelheim International Gmbh	Liquid phase separation of plasmid dna isoforms and topoisomers
EP3461481A1 (en)	2012-05-08	2019-04-03	Forum Pharmaceuticals Inc.	Methods of maintaining, treating or improving cognitive function
ES2865736T3 (es) *	2013-01-15	2021-10-15	Novartis Ag	Uso de agonistas del receptor de acetilcolina nicotínico alfa 7
KR101879921B1 (ko) *	2013-01-15	2018-07-18	노파르티스 아게	기면증의 치료를 위한 알파 7 니코틴성 아세틸콜린 수용체 작용물질의 용도
US20150313884A1 (en)	2013-01-15	2015-11-05	Novartis Ag	Use of alpha 7 nicotinic acetylcholine receptor agonists
EP3233087B1 (en)	2014-12-16	2019-10-02	Axovant Sciences GmbH	Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
JP2018516973A (ja)	2015-06-10	2018-06-28	フォーラム・ファーマシューティカルズ・インコーポレイテッドＦｏｒｕｍＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃ．	α７−ニコチン性アセチルコリン受容体のアゴニストとしてのアミノベンゾイソオキサゾール化合物
WO2017027600A1 (en)	2015-08-12	2017-02-16	Forum Pharmaceuticals, Inc.	GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3534053A (en) *	1967-05-24	1970-10-13	American Home Prod	Quinuclidine derivatives
SU495310A1 (ru) *	1974-03-05	1975-12-15	Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе	Хинуклидил-3-диарал(гетерил) карбинолы, про вл ющие антигистаминную, антисеротониновую и антиаллергическую активность и способ их получени
DE3718317A1 (de) *	1986-12-10	1988-06-16	Bayer Ag	Substituierte basische 2-aminotetraline
CA1307790C (en) *	1987-08-04	1992-09-22	Ian Anthony Cliffe	Ethers
US5405853A (en) *	1987-09-10	1995-04-11	Merck Sharpe & Dohme Ltd.	Thiadiazoles useful in the treatment of senile dementia
JP2752143B2 (ja) *	1988-04-01	1998-05-18	三共株式会社	カルバペネム誘導体
EP0363085A3 (en) *	1988-10-03	1991-03-27	Beecham Group Plc	Novel compounds
IT1227729B (it) *	1988-12-23	1991-05-06	Savio Spa	Procedimento e dispositivo per la rimozione delle fibre deteriorate durante il riattacco del filo in un filatoio open-end
YU84791A (sh) *	1990-05-19	1994-06-10	Boehringer Ingelheim Kg.	Biciklicni 1-aza-cikloalkalni
WO1992004333A1 (fr) *	1990-08-31	1992-03-19	Nippon Shinyaku Co., Ltd.	Derive de pyrimidine et medicament
ZA92278B (en) *	1991-02-01	1992-10-28	Akzo Nv	3-quinuclidine derivatives
GB9201749D0 (en) *	1992-01-28	1992-03-11	Smithkline Beecham Plc	Medicaments
US5948793A (en) *	1992-10-09	1999-09-07	Abbott Laboratories	3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
JPH09512804A (ja) *	1994-05-06	1997-12-22	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	５−ｈｔ１ｄアンタゴニストとして有用なビフェニルカルボキシアミド類
JPH0840999A (ja) *	1994-08-04	1996-02-13	Yamanouchi Pharmaceut Co Ltd	フルオロインダン誘導体
US5998404A (en) *	1994-10-24	1999-12-07	Eli Lilly And Company	Heterocyclic compounds and their use
US5821370A (en) *	1994-10-24	1998-10-13	Eli Lilly And Company	Heterocyclic compounds and their preparation and use
JPH08134067A (ja) *	1994-11-11	1996-05-28	Yamanouchi Pharmaceut Co Ltd	キヌクリジン誘導体
US5512574A (en) *	1994-12-21	1996-04-30	American Home Products Corporation	Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
US5852037A (en) *	1995-11-13	1998-12-22	Eli Lilly And Company	Method for treating anxiety
EP0773027A1 (en) *	1995-11-13	1997-05-14	Eli Lilly And Company	Use of azacyclic or azabicyclic pyrazine compounds for treating anxiety
US5763457A (en) *	1995-11-13	1998-06-09	Eli Lilly And Company	Method for treating anxiety
FR2754261B1 (fr) *	1996-10-08	1998-10-30	Synthelabo	Derives de quinuclidine, leur preparation et leur application en therapeutique
WO1998027983A1 (en) *	1996-12-20	1998-07-02	Novo Nordisk A/S	A method of treating hypercholesterolemia and related disorders
HN1998000118A (es) *	1997-08-27	1999-02-09	Pfizer Prod Inc	2 - aminopiridinas que contienen sustituyentes de anillos condensados.
FR2772378B1 (fr) *	1997-12-12	2000-02-04	Synthelabo	Derives d'imidazole, leur preparation et leur application en therapeutique
WO1999042461A1 (en) *	1998-02-23	1999-08-26	Warner-Lambert Company	Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
JP4616971B2 (ja) *	2000-07-18	2011-01-19	田辺三菱製薬株式会社	１−アザビシクロアルカン化合物およびその医薬用途
ATE385497T1 (de) *	2000-12-01	2008-02-15	Neurosearch As	3-substituierte quinuclidin-derivate und deren verwendung als nikotinischen agonisten

2003
- 2003-08-13 CA CA002493245A patent/CA2493245A1/en not_active Abandoned
- 2003-08-13 AU AU2003250322A patent/AU2003250322B2/en not_active Ceased
- 2003-08-13 WO PCT/DK2003/000538 patent/WO2004016608A1/en not_active Ceased
- 2003-08-13 KR KR1020057002514A patent/KR20050055711A/ko not_active Ceased
- 2003-08-13 JP JP2005502013A patent/JP2005538187A/ja active Pending
- 2003-08-13 CN CNB038190788A patent/CN100513406C/zh not_active Expired - Fee Related
- 2003-08-13 RU RU2005101748/04A patent/RU2323217C2/ru not_active IP Right Cessation
- 2003-08-13 EP EP03787742A patent/EP1532144B1/en not_active Expired - Lifetime
- 2003-08-13 EP EP08100204A patent/EP1905771A3/en not_active Withdrawn
- 2003-08-13 AT AT03787742T patent/ATE384720T1/de not_active IP Right Cessation
- 2003-08-13 PL PL03375533A patent/PL375533A1/xx not_active Application Discontinuation
- 2003-08-13 US US10/522,150 patent/US20050245567A1/en not_active Abandoned
- 2003-08-13 MX MXPA05001702A patent/MXPA05001702A/es active IP Right Grant
- 2003-08-13 DE DE60318860T patent/DE60318860T2/de not_active Expired - Lifetime
- 2003-08-13 BR BR0313153-0A patent/BR0313153A/pt not_active IP Right Cessation
- 2003-08-13 NZ NZ538058A patent/NZ538058A/en not_active IP Right Cessation
2005
- 2005-01-12 IL IL16625405A patent/IL166254A0/xx unknown
- 2005-03-11 NO NO20051264A patent/NO20051264L/no not_active Application Discontinuation
- 2005-03-14 IS IS7742A patent/IS7742A/is unknown
2008
- 2008-09-08 US US12/206,302 patent/US20090005390A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1905771A2 (en)	2008-04-02
US20090005390A1 (en)	2009-01-01
MXPA05001702A (es)	2005-04-19
AU2003250322B2 (en)	2010-01-21
DE60318860D1 (de)	2008-03-13
CN1675205A (zh)	2005-09-28
NZ538058A (en)	2006-11-30
DE60318860T2 (de)	2008-05-21
PL375533A1 (en)	2005-11-28
EP1905771A3 (en)	2008-11-26
EP1532144A1 (en)	2005-05-25
CA2493245A1 (en)	2004-02-26
KR20050055711A (ko)	2005-06-13
RU2323217C2 (ru)	2008-04-27
WO2004016608A1 (en)	2004-02-26
ATE384720T1 (de)	2008-02-15
HK1080860A1 (zh)	2006-05-04
EP1532144B1 (en)	2008-01-23
BR0313153A (pt)	2005-06-28
CN100513406C (zh)	2009-07-15
AU2003250322A1 (en)	2004-03-03
JP2005538187A (ja)	2005-12-15
IL166254A0 (en)	2006-01-15
US20050245567A1 (en)	2005-11-03
RU2005101748A (ru)	2006-01-20
NO20051264L (no)	2005-05-18

Publication	Publication Date	Title
IS7742A (is)	2005-03-14	Nýjar kvínúklidín-afleiður og notkun þeirra
DK1551835T3 (da)	2007-06-04	Hidtil ukendte 1,4-diazabicycloalkanderivater, deres fremstilling og anvendelse
IL186360A0 (en)	2008-01-20	Novel oxadiazole derivatives and their medical use
ATE385497T1 (de)	2008-02-15	3-substituierte quinuclidin-derivate und deren verwendung als nikotinischen agonisten
DE60310548D1 (de)	2007-02-01	Diazabicyclische biarylderivate
ATE287888T1 (de)	2005-02-15	Aryl- und heteroaryldiazabicycloalkane, deren zubereitung und verwendung
DK1562945T3 (da)	2007-03-05	Hidtil ukendte diazebicykliske biarylderivater
ATE289310T1 (de)	2005-03-15	Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren
DK1406900T3 (da)	2007-01-29	Hidtil ukendte forbindelser, fremstilling og anvendelse deraf
ATE445618T1 (de)	2009-10-15	Neue diazabicyclische arylderivate
MX2007004269A (es)	2007-06-15	Derivados de arilo diazabiciclico nuevos y su uso medico.
ATE437880T1 (de)	2009-08-15	Dimere azacyclische verbindungen und deren verwendung
DK1963323T3 (da)	2010-10-25	Hidtil ukendte diazabicykliske arylderivater og medicinsk anvendelse heraf
DE60307102D1 (de)	2006-09-07	3-substituierte chinuklidine und deren verwendung
ATE401334T1 (de)	2008-08-15	Neue azacyclische ethinylderivate
DE602004031124D1 (de)	2011-03-03	Neue chinuklidinderivative und deren pharmazeutische verwendung
ATE287404T1 (de)	2005-02-15	Diazabicyclo (2.2.1) heptanderivate
MX2007004245A (es)	2007-06-12	Nuevos derivados de arilo azabiciclicos y su uso medico.